As of 2025-05-30, the Gross Margin of IX Biopharma Ltd (42C.SI) is 17.6%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-06-30 | 17.6% |
2023-06-30 | 39.2% |
2022-06-30 | 85.4% |
2021-06-30 | -21.9% |
2020-06-30 | -59.6% |
2019-06-30 | -78.8% |
2018-06-30 | -100.4% |
2017-06-30 | 35.1% |
2016-06-30 | 29.4% |
2015-06-30 | 92.3% |